EUCERIN USE WITH Rx STEROID FOR ATOPIC DERMATITIS CUTS COSTS BY HALF for consumers by reducing steroid application from twice- to once-daily through the addition of use of the water-in-emollient moisturizer, according to results of a study performed by Anne Lucky, MD, et al., Dermatology Research Associates (Cincinnati, Ohio). Published in the July/August 1997 issue of Pediatric Dermatology, the study evaluated comparative regimens of once-daily application each of prescription hydrocortisone 2.5% cream and Beiersdorf's Eucerin Original creme against twice-daily application of the hydrocortisone treatment in 25 children with mild to moderate atopic dermatitis. Both regimens were found to be of "equivalent" efficacy, according to the study. Rx steroid treatments cost between $10 to $30 per ounce, while water-in-oil moisturizers such as Eucerin average around $1 an ounce, the researchers said.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
First Insight report from survey conducted in April with 1,267 US consumers notes that the Private Label Manufacturers Association recorded private label sales increasing by nearly 4% in 2024 to a record $271bn.
First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.
Bayer North America CFO with firm since 2008; Cosette VP for quality, regulatory affairs; FDA labeling review official joins ProPharma; Lifecykel, UFC veterans launch Mongolian training camp; and Beverly Hills surgeons offer skin care supplement.
